跳至主要内容
临床试验/NCT00104702
NCT00104702已完成2 期

Radio-Surgical Treatment of Breast Cancer of Women Aged Over 70: Phase II Trial of Feasibility and Reproducibility of a Concentrated and Focalized Radiotherapy

UNICANCER10 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2004年7月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
UNICANCER
入组人数
46
试验地点
10
主要终点
Reproducibility

研究概览

简要总结

RATIONALE: Radiation therapy uses high-energy x rays to kill tumor cells. Giving radiation therapy after surgery may kill any tumor cells that remain after surgery.

PURPOSE: This phase II trial is studying how well radiation therapy works in treating older women who are undergoing surgery for stage I or stage II breast cancer.

详细描述

OBJECTIVES:

Primary

  • Determine reproducibility of localized and concentrated adjuvant radiotherapy, in terms of isodose curve and dose heterogeneity, in older women with stage I or II breast cancer.

Secondary

  • Determine the impact of this regimen on Katz's Activity of Daily Living score and Lawton's Instrumental Activity of Daily Living score in these patients.
  • Determine relapse-free survival of patients treated with this regimen.
  • Determine overall and specific survival of patients treated with this regimen.
  • Determine the cosmetic result, as assessed by the patient, surgeon, and radiologist, of this regimen in these patients.
  • Determine the direct and indirect costs of this regimen in these patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •DISEASE CHARACTERISTICS:
  • •Diagnosis of invasive breast cancer
  • •Stage I or II disease
  • •Tumor size ≤ 30 mm
  • •Located in any breast quadrant
  • •No nodal involvement
  • •No inflammatory breast cancer
  • •No positive margins after surgical resection (performed on study)
  • •No microcalcifications
  • •Hormone receptor status
  • •Not specified
  • •PATIENT CHARACTERISTICS:
  • •Menopausal status
  • •Not specified
  • •Performance status
  • •Karnofsky 70-100%
  • •Life expectancy
  • •Not specified
  • •Hematopoietic
  • •Not specified
  • •Not specified
  • •Not specified
  • •PRIOR CONCURRENT THERAPY:
  • •Biologic therapy
  • •Not specified
  • •Chemotherapy
  • •Not specified
  • •Endocrine therapy
  • •Not specified
  • •Radiotherapy
  • •Not specified
  • •Not specified

排除标准

  • 未提供

研究组 & 干预措施

Concentrated and Focalized Radiotherapy

Experimental

干预措施: adjuvant therapy (Procedure)

Concentrated and Focalized Radiotherapy

Experimental

干预措施: conventional surgery (Procedure)

Concentrated and Focalized Radiotherapy

Experimental

干预措施: radiation therapy (Radiation)

结局指标

主要结局

Reproducibility

时间窗: 1 month

次要结局

  • Impact of localized and concentrated radiotherapy on Katz's Activity of Daily Living score and Lawton's Instrumental Activity of Daily Living score(3 weeks)
  • Relapse-free survival(1 year)
  • Overall and specific survival(1 year)
  • Cosmetic result(1 year)
  • Direct and indirect costs(1 month)

研究者

发起方
UNICANCER
申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验